STOCK TITAN
  1. Home
  2. Sec-filings
  3. GILD
  4. [Form 4] GILEAD SCIENCES, INC. Insider Trading Activity

[Form 4] GILEAD SCIENCES, INC. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock GILD logo
Gilead Sciences Inc

NASDAQ:GILD

GILD Rankings

#94 Ranked by Market Cap
#1398 Ranked by Dividends

GILD Latest News

Oct 13, 2025
Gilead and Kite Reinforce Bold Commitment to Transform Cancer Care With New Data at ESMO 2025
Oct 9, 2025
Gilead Sciences to Release Third Quarter 2025 Financial Results on Thursday, October 30, 2025
Sep 25, 2025
Gilead Foundation Grants $6.5 Million in Commitment to STEM Education
Sep 22, 2025
Ensoma Announces $53 Million Financing to Support Key Clinical Milestones for EN-374 and Continued Development of In Vivo Hematopoietic Stem Cell Engineering Pipeline
Sep 4, 2025
Gilead Announces Partnership With PEPFAR to Deliver Twice-Yearly Lenacapavir for HIV Prevention for up to Two Million People in Primarily Low- and Lower-Middle-Income Countries

GILD Latest SEC Filings

Oct 6, 2025
[8-K] GILEAD SCIENCES, INC. Reports Material Event
Sep 30, 2025
[Form 4] GILEAD SCIENCES, INC. Insider Trading Activity
Sep 29, 2025
[144] GILEAD SCIENCES, INC. SEC Filing
Sep 15, 2025
[144] GILEAD SCIENCES, INC. SEC Filing
Sep 15, 2025
[144] GILEAD SCIENCES, INC. SEC Filing

GILD Stock Data

145.40B
1.24B
0.1%
90.75%
1.42%
Drug Manufacturers - General
Biological Products, (no Disgnostic Substances)
Link
United States
FOSTER CITY